Amy Anderson Named Head of the Department of Pharmaceutical Sciences

Dean James R. Halpert announced the appointment of Dr. Amy C. Anderson as head of the Department of Pharmaceutical Sciences in the School of Pharmacy, effective May 7, 2015.  Anderson has extensive administrative and leadership experience, having served as assistant department head from 2008-2010, associate department head from 2010-2014 and as the interim head of the department from 2014-2015. Anderson received a B.S. in life sciences from MIT and a Ph.D. in biophysics from Harvard. She completed a postdoctoral fellowship in structure-based drug design at UCSF and joined the faculty of the University of Connecticut in 2006.

Anderson’s research expertise is in the use of structural information to design highly potent and selective enzyme inhibitors, understanding mechanisms of antibiotic resistance, including the structural basis of resistance, and the prediction of resistance mutations from structure. Her lab has been involved in the development of efficacious antifolates as antibacterial agents and recently, the tropolone class of compounds as emerging antibacterial and anticancer agents. Her work has received significant funding from the National Institutes of Health and the private sector. She has over 75 research publications in numerous journals including: Proceedings of the National Academy of Science, Chemistry and Biology, Journal of Medicinal Chemistry, and Antimicrobial Agents and Chemotherapy. She has received many honors and awards including the Connecticut Woman of Innovation in Research award.  She was elected to and serves as the co-chair of the Gordon Conference on Drug Resistance.

At the federal level, Anderson has served on a number of National Institutes of Health and National Science Foundation panels. In addition, she serves as chair of the Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section and has been a member on this panel for approximately 10 years.

“We extend our sincere appreciation to Dr. Anderson as she assumes the responsibilities of department head in pharmaceutical sciences. We are confident that she will be an excellent leader who will work closely with our faculty, students, post-doctoral fellows, and staff,” said Halpert.